Richard Gelber

17PUBLICATIONS
156CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersChinese languagesReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 17, 2025
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.

Fabio Conforti, Federico Merlo, Laura Pala

|Jul 09, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Fedro A Peccatori, Samuel M Niman, Ann H Partridge

|Jan 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

Fabio Conforti, Valentina Nekljudova, Isabella Sala

|Jan 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Stephen J Luen, Lauren C Brown, Courtney T van Geelen

|Sep 16, 2024
Reply to Z Wen et al and S Liu et al.

Hatem A Azim, Samuel M Niman, Ann H Partridge

|Sep 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick

Pageof 3

Frequent Collaborators

9 joint publications

Martine Piccart-Gebhart

6 joint publications

Sibylle Loibl

6 joint publications

Marco Colleoni

5 joint publications

Hervé R Bonnefoi